Evidence – Using Translational Models to Overcome Tumour Antigen Heterogeneity & Improve CAR-T Responses in Solid Tumours
Tumour Models London Summit 2026 · 2 December 2026 · 08:30
Evidence – Using Translational Models to Overcome Tumour Antigen Heterogeneity & Improve CAR-T Responses in Solid Tumours was a session at Tumour Models London Summit 2026 on 2 December 2026 in London, with 1 speaker on record.
Speakers
- John Bridgeman — Speaker CSO, ImmunoKey